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Abstract
A selective serotonin reuptake inhibitor is the most commonly prescribed antidepressant for
the treatment of major depression. However, the mechanisms underlying the actions of
selective serotonin reuptake inhibitors are not fully understood. In the dentate gyrus, chronic
fluoxetine treatment induces increased excitability of mature granule cells (GCs) as well as
neurogenesis. The major input to the dentate gyrus is the perforant path axons (boutons)
from the entorhinal cortex (layer II). Through voltage-sensitive dye imaging, we found that
the excitatory neurotransmission of the perforant path synapse onto the GCs in the middle
molecular layer of the mouse dentate gyrus (perforant path-GC synapse) is enhanced after
chronic fluoxetine treatment (15 mg/kg/day, 14 days). Therefore, we further examined
whether chronic fluoxetine treatment affects the morphology of the perforant path-GC syn-
apse, using FIB/SEM (focused ion beam/scanning electron microscopy). A three-dimen-
sional reconstruction of dendritic spines revealed the appearance of extremely large-sized
spines after chronic fluoxetine treatment. The large-sized spines had a postsynaptic density
with a large volume. However, chronic fluoxetine treatment did not affect spine density. The
presynaptic boutons that were in contact with the large-sized spines were large in volume,
and the volumes of the mitochondria and synaptic vesicles inside the boutons were corre-
lated with the size of the boutons. Thus, the large-sized perforant path-GC synapse induced
by chronic fluoxetine treatment contains synaptic components that correlate with the syn-
apse size and that may be involved in enhanced glutamatergic neurotransmission.
Introduction
Major depressive disorder is one of the most common psychiatric disorders, but the efficacy of
antidepressant medication is not sufficient [1, 2]. The monoamine and monoamine receptor
hypotheses of depression were derived from analyses of antidepressant action [3], but the
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mechanisms underlying its action are not fully understood [2, 4]. The induction of adult neuro-
genesis in the hippocampal dentate gyrus (DG) has been implicated in the therapeutic action
of antidepressants [5–7], and the upregulation of brain-derived neurotrophic factor (BDNF)
[8] contributes to the neurogenesis [8–10] as well as to the dendritic outgrowth and synaptic
plasticity [11] induced by antidepressants. Antidepressants were recently shown to increase the
excitability of mature granule cells (GCs) in the DG and to reduce the expression of mature GC
markers such as calbindin and tryptophan-2,3-dioxygenase [12]. These observations suggest
that the DG may be one of the therapeutic targets of antidepressants.
The DG receives excitatory inputs from the entorhinal cortex and functions as the main
gateway to the hippocampus. In the molecular layer of the DG, the perforant path from layer II
of the entorhinal cortex (medial subdivision) forms a synapse onto the dentate GCs (perforant
path-GC synapse). Chronic treatment with fluoxetine, one of the selective serotonin reuptake
inhibitors (SSRIs), induces an increase in the excitability of the dentate GCs, as previously
described [12], and alterations in the synaptic plasticity at perforant path-GC synapses [12–
14]. It has been reported that long-term potentiation (LTP) at perforant path-GC synapses is
enhanced by chronic fluoxetine under conditions of intact synaptic inhibition [14], although
reduced LTP and enhanced long-term depression (LTD) under disinhibited conditions with a
GABAA receptor inhibitor are reported [12]. It has been proposed that synaptic responses to
glutamatergic stimulation, which are determined as excitatory postsynaptic currents (EPSCs),
are positively correlated with the spine volumes [15], although conflicting findings on the cor-
relation of synaptic function with structure have been reported [16, 17]. Furthermore, an alter-
ation of synaptic plasticity is known to affect synaptic morphology and density, with larger or
more numerous spines in LTP and smaller or fewer spines in LTD [18]. Therefore, it is highly
possible that chronic fluoxetine treatment induces morphological changes in the perforant
path-GC synapses.
The information on antidepressant-induced alterations of spine morphology and density is
limited. Chronic fluoxetine treatment has been reported to increase spine density in the CA1
and CA3 regions of the hippocampus [19, 20]. McAvoy et al. recently reported that chronic flu-
oxetine treatment induces changes in spine density and size in the DG and CA1 in laminae-
specific input- and age-dependent manners [21]. In the DG, increases in spine density and size
were detected in the outer molecular layer of the dorsal DG in middle-aged mice (10 months of
age) but not in adult mice (4 months of age). Their study clearly demonstrated that chronic flu-
oxetine treatment induces morphological changes in the dendritic spines of the dentate GCs,
but the fine structures of the spines and presynaptic boutons were not evaluated due to limita-
tions in the fluorescent imaging of the dendritic spines.
Imaging with electron microscopy is required for the analysis of the fine structures of the
synapse in the nervous system. Due to the complexity of neural connections, three-dimensional
(3D) reconstruction using electron microscope images is desired. Serial section transmission
electron microscopy (ssTEM) has been used for 3D reconstruction, but ssTEM is time-con-
suming and technically demanding [22, 23]. To overcome the disadvantages, focused ion
beam/scanning electron microscopy (FIB/SEM) has been developed to acquire serial section
SEM images, which have been shown to be sufficient for the reconstruction of 3D images of the
synaptic connections and structures [22–25]. Recently, the FIB/SEM technique was success-
fully used to reconstruct 3D structures of the dendritic spines of adult-generated GCs and their
contacts with the boutons of the perforant path in the DG [26].
In this study, we performed voltage-sensitive dye imaging and found that glutamatergic
neurotransmission at the perforant path-GC synapses in the middle molecular layer of DG was
enhanced after chronic fluoxetine treatment. The functional upregulation of the perforant
path-GC synapse is likely associated with the reduced expression of mature GC markers [12].
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In the dorsal DG where mature GC markers are reduced after chronic fluoxetine, we quantita-
tively analyzed the chronic fluoxetine treatment-induced changes in the structures of the per-
forant path-GC synapses using FIB/SEM imaging and 3D reconstruction.
Materials and Methods
Animals
Male C57BL/6N mice were purchased from Japan SLC (Shizuoka, Japan). Mice were housed
2–4 per cage and were maintained on a 12-h light/dark cycle (lights on from 7:00 am to 7:00
pm) with access to food and water ad libitum. All of the mice used in this study were handled
in accordance with the Guide for the Care and Use of Laboratory Animals as adopted by the U.
S. National Institutes of Health, and the specific protocols were approved by the Institutional
Animal Care and Use Committee of Kurume University School of Medicine (Protocol Num-
bers 2012–057, 2013–077, 2014–026, and 2015–031).
Drug treatment
Male C57BL/6N mice at 10 weeks of age were treated with fluoxetine chronically by the subcu-
taneous implantation of matrix-driven delivery pellets (Innovative Research of America, Sara-
sota, FL, USA), which were designed to consistently release fluoxetine at a rate of 15 mg/kg/day
for 14 days. In the placebo group, the mice received subcutaneous implantation of pellets con-
taining only matrix for the same period.
Electrophysiology
The neuronal activities of the DG in the hippocampal slices were recorded by the use of a volt-
age-sensitive dye and an optical recording technique [27], as reported previously [28]. Mice
treated with placebo or fluoxetine pellets were sacrificed by decapitation. The brains were rap-
idly removed and immersed for 8–10 s in a cooled artificial cerebrospinal fluid (ASCF at
4–6°C) that was pre-bubbled with 95% O2/5% CO2. The composition of the ACSF was as fol-
lows (in mM): NaCl 117, KCl 4.7, CaCl2 2.5, NaHPO4 1.2, and D-glucose 11 (299 ± 4 mOsm,
pH 7.4). Horizontal brain slices (400 μm in thickness) were cut from the ventro-to-mid section
at -2.2 – -3.0 mm from the bregma by a Vibroslice (Campden Instruments, Loughborough,
Leics., UK). The brain slices were allowed to recover for 1 hour in the oxygenated ACSF at
room temperature (22–24°C), were then transferred to a recording chamber and were continu-
ously superfused with the oxygenated ACSF at a rate of 2–3 ml/min. The temperature of the
brain slices was maintained at 28.8–29.2°C in the recording chamber. The slices were sub-
merged in ACSF containing the voltage-sensitive dye RH-482 (0.1 mg/ml) (Nippon Kankoh-
Shikiso Kenkyusho, Okayama, Japan) for 15 min. A stained slice was mounted on an upright
microscope (Optiphoto-2, Nikon) equipped with a tungsten-halogen lamp (12 V/100 W),
interference filters (700 nm) and a mechanical shutter to control the duration of light exposure.
Optical images were acquired using a 128x128 photodiode array with a time resolution of 0.6
ms (HR Deltaron 1700, FUJIFILM, Tokyo, Japan). With a 10X objective and a 0.6X relay lens
(total 6X), each photodiode monitored an area of 11.5x11.5 μm2, and therefore, the whole
array monitored a tissue area of 1.48x1.48 mm2. The stained slice was illuminated by a 700 nm
light for 2 s every 10 s to minimize bleaching of the voltage-sensitive dye. To evoke optical sig-
nals, a concentric bipolar electrode was placed in the middle molecular layer of the hippocam-
pal DG, where the perforant path inputs to the GCs from the medial entorhinal cortex were
present. Before applying the stimulus, 128 picture frames of the averaged background image
were stored as reference light signals. These reference data were subtracted from real-time
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images taken after perforant path fiber stimulation and were transferred at an interval of 0.6
ms. During each light flash, the DG was stimulated with a single voltage pulse (30 V for 400 μs)
through a concentric bipolar electrode. Neuronal activity was detected as the ratio of the
absorption signals due to neuronal excitation (ΔI) to the background light signals taken before
stimulation of the DG (I0). One trial consisted of 512 sequential frames within 307 ms, and 16
trials were averaged to improve the signal-to-noise ratio. As a result, the background noise was
reduced to 5% of the neuronal signal intensity. The fractional change in the optical signal was
usually coded in a pseudocolor-scale. The temporal change of the optical signal was recorded
from several unit areas on the spreading pathway of the brain slice to examine the time course
of the optical signal. Each unit area corresponded to a 7x7 photodiode array (49 pixels) to
improve the signal-to-noise ratio. The absorption signal by RH-482 reversed the polarity with
an interference filter of 620 nm, which confirmed that the optical signal originated from RH-
482 rather than from intrinsic signals or other sources [29]. The drugs were purchased from
the following source: 6,7-dintroquinoxaline-2,3-dione (DNQX) and 2-Amino-5-phosphono-
pentanoic acid (APV) from Sigma-Aldrich (St. Louis, MO, USA).
Preparation of dentate gyrus samples for FIB/SEM
Mice were anesthetized with sodium pentobarbital and then perfused with 4% paraformalde-
hyde and 0.125% glutaraldehyde in phosphate buffer (0.1 M, pH 7.4). Three to four hours after
perfusion, the brains were removed, and coronal slices of the dorsal DG (300 μm) were cut
with a vibrating blade microtome (VT1000S, Leica Microsystems, Nussloch, Germany). The
slices were further fixed in a cacodylate buffer (0.1 M, pH 7.4) containing 2% paraformalde-
hyde and 2.5% glutaraldehyde for 6–12 hours at 4°C and were then washed with the same
buffer. The slices were postfixed in a cacodylate buffer (0.1 M, pH 7.4) containing 2% OsO4/
1.5% potassium ferrocyanide for 1 h on ice and were then washed five times with double dis-
tilled H2O (ddH2O). The slices were immersed in 1% thiocarbohydrazide for 1 h at 60°C. After
being washed five times in ddH2O, the slices were then further immersed in 2% aqueous OsO4
for 1 hour on ice and were washed five times with ddH2O. The slices were then en bloc stained
in a solution of 4% uranyl acetate dissolved in ddH2O overnight at 4°C and were washed five
times with ddH2O. The slices were then further stained with Walton’s lead aspartate solution
for 1 h at 60°C [30], dehydrated in an ethanol series (20%, 50% 70%, 90% and twice 100% for
10 min each), placed in ice-cold dry acetone for 10 min, subjected to infiltration of an epoxy
resin (Epon 812, TAAB, England) mixture, and polymerized for 72 h at 60°C [25].
Preparation of dentate gyrus samples with Golgi stain for FIB/SEM
Under deep anesthesia with sodium pentobarbital, the mice were perfused with phosphate
buffer (0.1 M, pH 7.4) containing 4% paraformaldehyde and 1% glutaraldehyde and then with
the same phosphate buffer containing 2% paraformaldehyde and 1% glutaraldehyde [31].
Three to four hours after perfusion, the brains were removed and processed using the Rapid
GolgiStain kit according to manufacturer’s instructions (FD NeuroTechnologies, Columbia,
MD, USA). The Golgi-stained slices of the DG (200 μm) were further processed with the proto-
col for FIB/SEM samples following en bloc staining.
Imaging with FIB/SEM
The embedded slices were placed on a metal stub and further trimmed with glass and diamond
knives in an ultramicrotome (Ultracut E microtome, Leica, Wetzlar, Germany). The slices were
coated with a protective layer of carbon, which prevented any charge. The metal stub with the
slices was set on the stage of FIB/SEM. The serial section images in the middle molecular layer
Perforant Path-GC Synapses after Chronic Fluoxetine
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of the dorsal DG were automatically obtained by FIB/SEM (Quanta 3D FEG, FEI, Hillsboro,
OR, USA). Serial images of the block face were acquired by repeated cycles of sample surface
milling and imaging using the Slice & View G2 operating software (FEI). The milling was per-
formed with a gallium ion beam at 30 kV with a current of 1.0 nA or 3.0 nA (Golgi stain). The
milling pitch was set to 15 or 30 (Golgi stain) nm/step. The images were acquired at an acceler-
ating voltage of 2.5 kV. The other acquisition parameters were as follows: dwell time = 6 s/
pixel, pixel size = 4.9 and 14.6 (Golgi stain) nm/pixel.
Three-dimensional reconstruction and analysis
The serial section images were reconstructed to 3D images and were analyzed using Amira
5.4–5.5 software (FEI). The postsynaptic [e.g., dendritic spine and postsynaptic density (PSD)]
and presynaptic (e.g., presynaptic bouton, synaptic vesicle and mitochondria) components
were manually traced, and the volume of each component was measured using Amira. For the
analyses of the postsynaptic components, three dendrites were traced from each mouse. The
spines were classified into regular- and large-sized spines. A regular-sized spine was defined as
having a spine volume less than or equal to the mean value + 2 standard deviations (SDs) of
the volume obtained in the placebo groups (0.25 μm3), and a large-sized spine was defined as
a spine with a volume greater than mean + 2SDs (>0.25 μm3). PSDs were identified as a band
of electron-dense materials at asymmetrical synapses. For the analyses of the presynaptic com-
ponents, the presynaptic boutons were classified by their connections to spines with different
sizes (Group 1: spine volume<mean (0.076 μm3), Group 2: mean spine volume<mean
+ SD (0.162 μm3), Group 3: mean + SD spine volume<mean + 2 SDs (0.249 μm3), Group
4: mean + 2SDs spine volume) by using the mean and SD values from the placebo groups.
Statistical analysis
The data are shown as the means ± SEM. Statistical analyses were performed using Student’s t-
test, Mann-Whitney U-test, one-way ANOVA and two-way ANOVA (GraphPad Prism,
GraphPad Software, San Diego, CA, USA), as indicated in figure legends.
Results
Neural activity of perforant path synapses in the DG after chronic
fluoxetine treatment
The spatiotemporal propagation of neuronal excitation was recorded from neurons in the mid-
dle molecular layer of the hippocampal DG, where the perforant path inputs from layer II of
the entorhinal cortex form synaptic connections with the dendritic spines of GCs (S1A–S1C
Fig). The application of a single electrical stimulation (30 V for 400 μs) to the perforant path
inputs in the middle molecular layer of the DG resulted in depolarizing optical responses adja-
cent to the stimulated site with a latency of 1.2 ms and their spreading in the middle molecular
layer (Fig 1A and S1C Fig). The optical responses observed 7.2–9.6 ms after the electrical stim-
ulation were considered to reflect the excitation of GC dendrites because the responses were
blocked by AMPA and NMDA receptor antagonists (S1C and S1D Fig). The maximum propa-
gation area of the optical signal observed 7.2–9.6 ms after nerve stimulation was determined by
counting the number of pixels in which the evoked depolarizing optical signal was above the
background noise. Pooled data showed that the maximum propagation area of the neuronal
excitation was larger in the fluoxetine-treated mice than in the placebo-treated mice (Fig 1B
and 1C). Analysis of the input-output relationship revealed that chronic fluoxetine treatment
increased the amplitude of optical responses and the gain of the input-output curve (S2 Fig),
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although time course of the optical responses was not affected (Fig 1B and S2 Fig). Taken
together, the efficacy of excitatory neurotransmission is enhanced in the perforant path-GC
synapse in the fluoxetine-treated mice.
Morphological changes in the spines of the perforant path-GC synapse
in the DG after chronic fluoxetine treatment
We evaluated the effect of chronic fluoxetine treatment on the morphology of the perforant
path-GC synapses in the middle molecular layer of the dorsal DG using serial images obtained
with FIB/SEM (S3 Fig). Mice were treated with a fluoxetine pellet, which was designed to
release fluoxetine at a constant rate of 15 mg/kg/day for 2 weeks. The 3D reconstruction of
serial SEM images made it possible to visualize the EM-quality ultrastructure of the dendritic
spines containing postsynaptic densities (PSDs) and the presynaptic boutons containing vesi-
cles and mitochondria in the middle molecular layer of the DG (Fig 2). After chronic fluoxetine
treatment, large-sized spines appeared in the dendritic spines of the GCs in the middle molecu-
lar layer. The large-sized spines contained large PSDs and formed contacts with the large bou-
tons of the perforant path (Fig 2E and 2F).
We then quantitatively analyzed the spine volume. The volume of each spine was quanti-
tated using 3D reconstructed images of dendrites. Spines with a large volume were observed in
Fig 1. Effect of chronic fluoxetine treatment on optical responses in the hippocampal DG. (A) Effect of chronic fluoxetine treatment on optical
responses evoked by the stimulation of the perforant path inputs in hippocampal slices. The left-most panel shows the pseudocolor image of the slice
preparation in which the optical recordings were made. A series of optical images of neuronal activity were recorded at 1.2-ms intervals from 0 to 10.8 ms
after nerve stimulation. The signal intensity, expressed as fractional changes in optical absorbance relative to the background (%), was coded by the
pseudocolor image. (B, C) The maximum propagation area of the optical signal above the background noise was analyzed 7.2–9.6 ms after stimulation,
when the activation of the dendrites of the GCs via glutamatergic synaptic transmission was detected (see S1 Fig). Typical images of the excitation area (B),
traces of the optical responses at the boxed area (B) and the quantified excitation area (C) are shown in mice treated with placebo (n = 16 slices from 8 mice)
and fluoxetine (n = 19 slices from 9 mice). *p < 0.001 compared with placebo-treated mice; Mann-Whitney U-test (U = 50, p = 0.0008). The preliminary data
used for these figures are reported in a review article in Japanese [71].
doi:10.1371/journal.pone.0147307.g001
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Fig 2. Three-dimensional reconstruction of perforant path-GC synapses in the dentate gyrus. (A, B) Full field SEM images obtained through FIB/SEM
show the cross-sections of dendrites (green) in the placebo- (A) and fluoxetine (B)-treated mice. Insets show images of dendritic spines (green) and
connecting boutons obtained in other sections. The arrows (red) indicate PSD. (C, D) 3D-reconstructed dendritic segments in the middle molecular layer of
the DG in the placebo- (C) and fluoxetine (D)-treated mice. Note the appearance of the large-sized spines and PSDs (red) in the fluoxetine-treated mice. The
dendritic spines, which are shown in the insets of Fig 1A and 1B, are indicated with numbers. (E, F) Three-dimensional reconstructed presynaptic boutons
are visualized at two synapses in the placebo- (E) and fluoxetine (F)-treated mice. The synaptic vesicles (orange) and mitochondria (purple) are shown inside
the presynaptic boutons. Note that the large-sized spines are in contact with large-sized presynaptic boutons. Scale bars: 1 μm.
doi:10.1371/journal.pone.0147307.g002
Perforant Path-GC Synapses after Chronic Fluoxetine
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all three fluoxetine-treated mice (Fig 3A). The mean value of the spine volume was significantly
higher in the fluoxetine-treated mice than in the placebo-treated mice (Fig 3B), although the
spine densities in the placebo- and fluoxetine-treated mice were similar (Fig 3C).
To classify the spines into regular- and large-sized spines, a large-sized spine was defined as
a spine with a volume greater than or equal to the mean value + 2SDs of the placebo-treated
mice (0.249 μm3). The percentages of large-sized spines were 5.3% and 11.4% in the placebo-
and fluoxetine-treated mice, respectively. Histogram analyses of the spine volume revealed that
the distribution of spine volumes of in regular-sized spines in the placebo- and fluoxetine-
treated mice were similar (S4A and S4B Fig), but that, among large-sized spines, spines with
extremely large volume (0.50 μm3) appeared after fluoxetine treatment (S4C Fig). In addi-
tion, the analysis of large-sized spines revealed multisynaptic spines that formed contacts with
at lease two presynaptic boutons [32, 33] in three spines with volumes of 0.34, 0.65 and
1.02 μm3, and these were only found in the fluoxetine-treated mice (S5 Fig).
To avoid any bias in selection of dendrites with large-sized spines in the fluoxetine-treated
mice, dendrites stained by chance with Golgi’s method were selected for the spine volume anal-
ysis (S6A Fig). All densely stained dendrites were subjected to 3D reconstruction, and the spine
volume was quantitated. The 3D-reconstructed images of the Golgi-stained dendrites revealed
the appearance of the large-sized spines after chronic fluoxetine treatment (S6A Fig). An
increase in the spine volume in the Golgi-stained dendrites was observed in the fluoxetine-
treated mice (S6B Fig). As expected, the spine density was not affected by the chronic fluoxe-
tine treatment (S6C Fig). The results obtained from the Golgi-stained dendrites were consistent
with those from manually selected dendrites (Fig 3).
Fig 3. Spine volume and density in the placebo- and fluoxetine-treatedmice. (A) The scatter plot shows
the spine volume in mice treated with placebo (n = 207 spines from 9 dendrites, 3 dendrites per each of 3
mice) or fluoxetine (n = 175 spines from 9 dendrites, 3 dendrites per each of 3 mice). (B, C) Mean values of
spine volume for all spines (Mann-WhitneyU-test: U = 15930, p = 0.0425) (B) and spine density (Mann-
WhitneyU-test: U = 28, p = 0.2973) (C) in the placebo- or fluoxetine-treated mice. *p < 0.05 compared with
the placebo-treated mice.
doi:10.1371/journal.pone.0147307.g003
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Effect of chronic fluoxetine treatment on PSDs of dendritic spines
We then evaluated the effect of chronic fluoxetine treatment on the PSD volume in each spine.
PSDs with a large volume were mainly found in the fluoxetine-treated mice (Fig 4A). The
mean PSD volume was significantly higher in the fluoxetine-treated mice than in the placebo-
treated mice (Fig 4B). A significant correlation between PSD volume and spine volume was
found in both the placebo- and fluoxetine-treated mice (Fig 4C), as had been previously
reported [34]. However, this correlation was not affected by chronic fluoxetine treatment.
When the spines were divided into regular and large-sized spines, a similar correlation between
PSD and spine volumes was obtained in the regular-sized spines (S7A Fig). In the large-sized
spines, the PSD volume did not correlate with the spine volume in the fluoxetine-treated mice
(S7B Fig), suggesting that the PSD volume in the large-sized spines was already large and did
not show an additional increase following the increase in spine volume.
Effect of chronic fluoxetine treatment on presynaptic boutons in contact
with spines of different sizes
The volume of the presynaptic boutons in contact with spines of different sizes was evaluated.
The spines were classified into four groups according to size (Groups 1–4) (Fig 5A, see
Method). The regular-sized spines (spine volume<mean + 2SDs) were subdivided into three
groups (Group 1–3), and the spines in Group 1–3 were in contact with boutons with similar
volume in both the placebo- and fluoxetine-treated mice (Fig 5A and 5B). The large-sized
spines, which were defined as Group 4 (mean + 2SDs spine volume), were in contact with
Fig 4. PSD volume and its correlation with spine volume. (A) Scatter plot showing the PSD volume in
mice treated with placebo (n = 173 PSDs from 9 dendrites, 3 dendrites per each of 3 mice) or fluoxetine
(n = 160 PSDs from 9 dendrites, 3 dendrites per each of 3 mice). (B) Mean values of the PSD volume in the
placebo- and fluoxetine-treated mice. *p < 0.05 compared with placebo-treated mice; Mann-Whitney U-test
(U = 11920, p = 0.0284). (C) Correlation between the PSD volume and spine volume in the placebo or
fluoxetine-treated mice. The fitted lines for the mice treated with placebo (r2 = 0.63, p < 0.0001) or fluoxetine
(r2 = 0.64, p < 0.0001) were obtained through a linear regression analysis.
doi:10.1371/journal.pone.0147307.g004
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Fig 5. Characterization of presynaptic boutons connected to spines of different sizes. (A) Presynaptic boutons were classified by their connections to
spines with different sizes. The spines were subdivided into four groups (Groups 1–4) based on the mean and SD values of the spine volume in placebo-
treated mice. Typical images of SEM and 3D reconstructed spines (green) and connected boutons (light brown) are shown. Synaptic vesicles (orange) and
Perforant Path-GC Synapses after Chronic Fluoxetine
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boutons with larger volume than those in Group 1, 2 or 3 in both groups of mice (Fig 5A and
5B). The relationship between spine and bouton volumes was not affected by chronic fluoxe-
tine treatment.
It is well known that the volumes of the mitochondria and synaptic vesicles in presynaptic
boutons are associated with synaptic activity [35, 36]. We therefore examined whether the vol-
ume of mitochondria or synaptic vesicles correlates with the volume of the presynaptic bou-
tons. The total mitochondria volume was positively correlated with the presynaptic bouton
volume (Fig 5C), and similar correlations were found in the placebo- and fluoxetine-treated
mice. In the boutons in contact with the Group 4 spines, 60% of spines (6/10 spines) in the flu-
oxetine-treated mice, but only 16.7% of spines (1/6 spines) in the placebo-treated mice, con-
tained two or three mitochondria. However, the size of each mitochondrion was similar
despite the number of mitochondria in a presynaptic bouton (data not shown). Furthermore,
the volume of all of the synaptic vesicles in each bouton correlated with the volume of the bou-
tons (Fig 5D). These results suggested that the presynaptic bouton in contact with the large-
sized spine was large in volume and contained mitochondria with a large volume and a large
amount of synaptic vesicles.
Discussion
The imaging of neural tissues using FIB/SEM and 3D reconstruction of the synapse from serial
EM images is a powerful technique for analyzing the fine structures of synaptic components.
Using this technique, the present study demonstrated that chronic fluoxetine treatment
induced the appearance of large-sized perforant path-GC synapses without affecting spine den-
sity in the middle molecular layer of the DG, where excitatory synaptic transmission was
expected to be enhanced after chronic fluoxetine, as found with voltage-sensitive dye imaging
and reported previously [12–14]. At the perforant path-GC synapses with large-sized spines,
the large-sized spines were connected to large-sized boutons. The large-sized spines contained
large-sized PSDs, and the large-sized boutons contained synaptic vesicles and mitochondria
with large sizes in correlation with the bouton volume. Thus, large-sized perforant path-GC
synapses appeared after chronic fluoxetine treatment and had pre- and post-synaptic compo-
nents required for excitatory synaptic transmission, suggesting that the enlarged perforant
path-GC synapse may contribute to chronic fluoxetine treatment-induced synaptic plasticity,
resulting in enhanced excitatory synaptic transmission.
Alterations of spine morphology after chronic fluoxetine treatment
Chronic fluoxetine treatment induced the appearance of large-sized spines in the middle
molecular layer of the DG. Several studies have previously demonstrated that chronic fluoxe-
tine treatment induced synaptic remodeling, such as changes in spine density and size in the
hippocampus. In ovariectomized female rats, chronic fluoxetine (5 mg/kg/day, i.p. for 5–14
days) has been shown to increase the density of spine synapses on pyramidal cells in the
mitochondria (purple) are shown inside the presynaptic boutons. Scale bars: 1 μm. (B) Volume of presynaptic boutons connected to spines classified as
Groups 1–4. n = 6–10 presynaptic boutons in each group. No significant difference between placebo and fluoxetine with two-way ANOVA (drug effect, F(1,44)
= 0.0682, p < 0.794; group effect, F(3,44) = 11.5, p < 0.0001; drug and group interaction, F(3,44) = 0.230, p = 0.875). One-way ANOVA: placebo, F(3,20) = 4.48,
p = 0.0147; fluoxetine, F(3,24) = 7.81, p = 0.0008; Bonferroni’s post-hoc test, *p < 0.05, compared with Group 1 in placebo,
†p < 0.05 compared with Group 2
in placebo, **p < 0.01 compared with Group 1 in fluoxetine, ††p < 0.01 compared with Group 2 in fluoxetine, §p < 0.05 compared with Group 3 in fluoxetine.
(C) Correlation between volumes of mitochondria and presynaptic boutons in mice treated with placebo (r2 = 0.79, p < 0.0001) or fluoxetine (r2 = 0.84,
p < 0.0001) with linear regression analysis. The symbol indicates the number of mitochondrion in each presynaptic bouton:●, one; , two;▲, three. The
mitochondrial volume is the sum of the volume for all of the mitochondria in each bouton. (D) Correlation between the volumes of synaptic vesicles and
presynaptic boutons in mice treated with placebo (r2 = 0.91, p < 0.0001) or fluoxetine (r2 = 0.72, p < 0.0001) with linear regression analysis.
doi:10.1371/journal.pone.0147307.g005
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stratum radiatum of the CA1 and CA3 regions as determined through images from a transmis-
sion electron microscope (TEM) [19]. In normal male mice, chronic fluoxetine treatment (16
mg/kg/day in drinking water for 28 days) also increased the spine density along the apical den-
drites of the pyramidal cells in the CA1 region, as determined through an analysis of Golgi-
stained images [20]. Regarding spine morphology, chronic fluoxetine treatment (0.7 mg/kg/
day, i.p. for 28 days) is shown to increase mature, mushroom-type spines as well as spine den-
sity at the Schaffer collateral-CA1 synapse, but not at the perforant path-CA1 synapse, in
Golgi-stained images [37]. McAvoy et al. reported that the hippocampus of middle-aged female
mice (10 months of age) was more sensitive to fluoxetine-induced synaptic remodeling than
the hippocampus of adult female mice (4 months of age), as demonstrated through an analysis
of fluorescent images in Thy1-GFP mice, in which mature granule cells and CA1 pyramidal
cells were genetically labeled with GFP [21]. In the outer molecular layer of the DG, chronic
fluoxetine treatment (18 mg/kg/day in drinking water for 28 days) induced an increase in spine
density and a shift of the spine head diameter distribution toward larger spines in mature gran-
ule cells in middle-aged mice but not adult mice [21].
Chronic fluoxetine treatment-induced increases in spine density have been detected in sev-
eral regions of the hippocampus (DG, CA3 and CA1) under various experimental conditions
(e.g., mouse and rat, male and female, age, dose and duration of fluoxetine, imaging method)
[19–21]. However, an increase in spine density after chronic fluoxetine treatment was not
observed in this study. It is possible that the remodeling of the spine density is less sensitive to
fluoxetine in the middle molecular layer of the DG compared to the outer molecular layer of
the DG or other hippocampal areas [21]. Regarding the spine size, one study [21] evaluated the
effect of fluoxetine on the spine size in the hippocampus using fluorescent images. Our study
constitutes the first morphological analysis using EM-quality images. The 3D reconstruction of
spine structure using FIB/SEM images is a sensitive technique for detecting changes in spine
morphology and therefore allowed the detection of the chronic fluoxetine treatment-induced
appearance of large-sized spines in the middle molecular layer of the DG in adult mice.
Chronic fluoxetine treatment has been shown to enhance adult neurogenesis in the DG [5,
6]. After chronic fluoxetine treatment, a larger number of newborn granule cells can be inte-
grated into the hippocampal circuitry compared with that observed under control conditions.
Newborn granule cells within 4 weeks are estimated to equal 6% of the total granule cells in the
rat DG [38]. Even taking into account the fact that chronic fluoxetine treatment increases pro-
liferating cells by 40–60% in the subgranular zone of the DG [5, 6, 39], the majority (>90%) of
GCs consist of mature neurons. As large-sized spines were detected in eight out of nine den-
drites in the fluoxetine-treated mice (see Fig 3A), the possibility that the detection of large-
sized spines after chronic fluoxetine treatment was due to the replacement of GCs with newly
integrated neurons is very low. Taken together, the data show that chronic fluoxetine treatment
likely induces changes in spine morphology in the preexisting mature GCs.
Mechanisms for spine enlargement have been investigated intensively under various experi-
mental conditions [15, 40]. BDNF/TrkB signaling plays a critical role in spine enlargement
associated with synaptic plasticity [41, 42]. In fact, chronic fluoxetine treatment increases the
BDNF levels in the hippocampus [43], and an increase in the BDNF level in the DG was
observed in our experimental conditions (Kuroiwa M and Shuto T, unpublished observation),
suggesting that the upregulation of BDNF/TrkB signaling may have contributed to the fluoxe-
tine-induced enlargement of the spines. However, this up-regulation of BDNF/TrkB signaling
and the subsequent changes in spine morphology likely occurred at the selected spines and not
evenly at all of the spines. The selection of spines could have been due to the high excitability of
the selected spines [44, 45] or to the connected perforant path boutons [46, 47], although this
suggestion is highly speculative.
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Enlarged presynaptic boutons connected to large-sized spines after
chronic fluoxetine treatment
Large-sized spines induced by chronic fluoxetine treatment were connected to boutons with a
large size, and the correlation of the spine and bouton volumes was maintained after chronic
fluoxetine treatment. The function and/or morphology of presynaptic boutons is regulated by
neural activity [48], cell adhesion molecules [49], and secreted factors [50], including BDNF
[51, 52], Wnt7 [53, 54] and fibroblast growth factor 22 (FGF22) [55, 56]. Antidepressants are
known to upregulate secreted factors (e.g., BDNF, VEGF, FGF and Wnt) and their downstream
signaling [57], and these factors, most notably BDNF, are expected to contribute to the enlarge-
ment of the boutons after chronic fluoxetine treatment.
In general, neurons with high activity have large boutons compared with neurons with low
activity [56]. However, Schikorski et al. [58, 59] indicated that bouton sizes in various types of
neurons show a 10-fold difference. Even along single axons, boutons are heterogeneous, and
their sizes are variable [60]. These findings suggest that neural activity may be one of the factors
that regulate the size of the boutons, but many other factors regulate bouton morphology. Flu-
oxetine-induced plasticity at the perforant path-GC synapses can be attributable to changes in
neural activity at the presynaptic boutons [14] as well as at the postsynaptic spines [12, 14].
Wang et al. [14] reported that chronic fluoxetine treatment induced a reduction of paired pulse
depression at the perforant path-GC synapses. It is possible that similar mechanisms with the
presynaptic plasticity may be involved in bouton enlargement. The precise mechanisms for
bouton enlargement after chronic fluoxetine need to be clarified.
Function of fluoxetine-induced large-sized synapses
Postsynaptic spine function. It has been reported that spine size is correlated with PSD
size and synaptic strength [34]. Meyer et al. [46] recently reported that synaptic plasticity
induced by glutamate uncaging accompanies a balanced enlargement of the spines, PSD and
boutons in a CA1 slice culture, suggesting that the correlated enlargement of the synaptic com-
ponents is essential for the enhancement of synaptic strength. In our study, the fluoxetine-
induced large-sized spine contained large-sized PSDs. PSDs are correlated with spines in terms
of volumes when analyzed with all- or regular-sized spines, but this correlation was lost in the
fluoxetine-induced large-sized spines. Because the PSD volume in the large-sized spines was
markedly larger than that in the regular-sized spines, the increase in PSD volume in the large-
sized spines may have already saturated the potential to further increase the PSD volume. In
addition, the fluoxetine-induced large-sized spines contained the spine apparatus (data not
shown) [61], and 15% of them were connected to multiple boutons (multisynaptic spine) [32,
33]. These findings suggest that the large-sized spines may be associated with increased synap-
tic transmission.
Chronic treatment with antidepressants has been considered to facilitate neural plasticity
[62, 63]. However, some studies failed to detect the facilitation of LTP by chronic fluoxetine
treatment [37, 64]. Rubio et al. [37] reported that chronic fluoxetine induced deficits in LTP
and LTD at the Schaffer collateral-CA1 synapse. The deficits in LTP and LTD seem to be asso-
ciated with the increases in spine density and mushroom-type spines, because LTP or LTD was
not affected in the perforant path-CA1 synapse where spine morphology was unaltered. Fur-
thermore, fluoxetine-induced mushroom-type spines have been shown to recruit Ca2+-imper-
meable, GluA2-containing AMPA receptors at PSD in the cerebral cortex [65], suggesting that
the decrease in Ca2+ permeability via AMPA receptors may result in deficits in synaptic plastic-
ity [37]. Thus, fluoxetine induces alteration of synaptic plasticity by affecting molecular com-
ponents, and such factors should be taken into account for functional interpretation.
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Presynaptic bouton function. The mitochondria and synaptic vesicles inside the large-
sized boutons were large in correlation with the bouton volume. The findings are consistent
with previous reports showing the correlation of mitochondria [66] or synaptic vesicles [67,
68] with bouton volume. Prior evidence that the mitochondria in the boutons enhance synaptic
vesicle release [35] and that the increased amounts of synaptic vesicles are related to the
increased synaptic transmission [69] suggest that the enlarged presynaptic boutons have an
increased ability of excitatory synaptic transmission.
The large-sized perforant path-GC synapses induced by chronic fluoxetine consist of pre-
synaptic boutons and postsynaptic spines with large components that facilitate the excitatory
synaptic transmission. The facilitation of excitatory inputs to the hippocampus may play a crit-
ical role in adjustment of hippocampal networks in response to antidepressant medication,
leading to gradual improvements in disturbed information processing within affected neural
networks [70].
Conclusions
The 3D reconstruction of perforant path-GC synapses using FIB/SEM images allowed success-
fully visualization of the complex structures of the pre- and post-synaptic components. Three-
dimensional images with quantitative data revealed that chronic fluoxetine treatment resulted
in the appearance of large-sized synapses, which may be functionally related to enhanced syn-
aptic transmission.
Supporting Information
S1 Fig. Optical responses in the DG evoked by stimulation of the perforant path inputs. (A,
B) A pseudocolor image of the slice preparation in which optical recordings were made (A)
and a schematic illustration of a hippocampal slice (B). The position of electrical stimulation
(30 V for 400 μs) in the middle molecular layer of the DG is indicated. (C) Optical responses
evoked by electrical stimulation in a hippocampal slice. A series of optical images of neuronal
activity was recorded at 1.2-ms intervals from 0 to 10.8 ms after nerve stimulation in the
absence (-) or presence (+) of an AMPA receptor antagonist, DNQX (20 μM), and an NMDA
receptor antagonist, APV (40 μM). The time after stimulation is indicated at the top of each
panel. All records were taken from the same slice. The signal intensity, expressed as the frac-
tional change in optical absorbance relative to the background (%), was coded based on a pseu-
docolor scale. (D) The amplitude of the optical signal after stimulation was recorded at three
positions (#1, #2, #3) located at different distances from the stimulatory electrode. The arrow-
heads indicate the time of stimulation. At position of #3 (500 μm from the stimulation elec-
trode), optical responses were completely blocked by DNQX plus APV. The ordinate and
abscissa scale bars indicate the fractional change in light intensity and time, respectively.
(TIF)
S2 Fig. Input-output relationship of the optical responses. (A) Traces of the optical
responses evoked by stimulus intensities of 6, 10 and 30 V at position #3 (S1D Fig) in hippo-
campal slices. (B) The input-output relationship of the optical responses in mice treated with
placebo (n = 10 slices from 5 mice) and fluoxetine (n = 12 slices from 6 mice). Signal intensity
is expressed as the fractional change in optical absorbance relative to the background (%). Data
represents means ± SEM. Two-way repeated measures ANOVA: drug effect, F(1,100) = 5.090,
p< 0.0354; time effect, F(5,100) = 109.1, p< 0.0001; drug and time interaction, F(5,100) = 2.661,
p = 0.0266); Bonferroni’s post-hoc test: p< 0.05 compared with placebo.
(TIF)
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S3 Fig. Analysis area of the middle molecular layer of the dorsal DG for FIB/SEM imaging.
(A) Schematic view of the FIB/SEM apparatus and the stained hippocampal slice embedded in
epoxy resin. Serial sample surface milling was performed with a focused Ga ion beam (FIB), and
each surface was imaged by SEM. (B, C) Analysis area in the middle molecular layer (MML) of
the dorsal DG at low (80x) (B) and high (250x) (C) magnification. At the analysis area (black
rectangle), serial SEM images were obtained by repeated surface milling with FIB. OML, outer
molecular layer; IML, inner molecular layer; GCL, granule cell layer; SGZ, subgranular zone.
(TIF)
S4 Fig. Distribution of spine volume in regular and large-sized spines in the placebo- and
fluoxetine-treated mice.Histogram analyses of the spine volume of all spines (A), regular-
sized spines (B) and large-sized spines (C) in the placebo- or fluoxetine-treated mice. The
large-sized spine was defined as the spine with a volume greater than or equal to the mean
value + 2SDs of the placebo-treated mice ( 0.249 μm3). Green and yellow boxes indicate the
regular- and large-sized spines, respectively.
(TIF)
S5 Fig. Multisynaptic spines in the fluoxetine-treated mice. (A) A field SEM image showing
the cross-section of a multisynaptic spine and a 3D reconstructed image of a multisynaptic
spine in a fluoxetine-treated mouse. The multisynaptic spine connected to two axons, axon 1
(red) and axon 2 (blue). (B, C) Tables show the percentage of multisynaptic spines in large-
sized spines (B) and the volume of multisynaptic spines and number of connected axons (C).
(TIF)
S6 Fig. Analysis of spine volume in the Golgi-stained dendrites. (A) Three-dimensional
reconstruction of dendritic spines stained with the Golgi’s method using FIB/SEM. Golgi stain-
ing was performed in two placebo- and two fluoxetine-treated group. All of the following
stained dendrites in the serial SEM images were analyzed: placebo 1 (n = 311 spines/4 den-
drites), placebo 2 (n = 922 spines/13 dendrites), fluoxetine 1 (n = 138 spines/2 dendrites) and
fluoxetine 2 (n = 260 spines/4 dendrites). (B, C) Mean spine volume and density in the placebo-
or fluoxetine-treated mice.
(TIF)
S7 Fig. Correlation between the PSD volume and spine volume in the regular and large-
sized spines. (A) In the regular-sized spines, similar correlations between the PSD and spine vol-
umes were obtained in the placebo- and fluoxetine-treated mice (Placebo: r2 = 0.28, p< 0.0001;
Fluoxetine: r2 = 0.44, p< 0.0001) with linear regression analysis. (B) In the large-sized spines of
the fluoxetine-treated mice, the PSD volumes were not significantly correlated with the spine vol-
ume (r2 = 0.13, p = 0.118). In the placebo-treated mice, a linear regression analysis was not per-
formed because most of the spine volume was distributed in a narrow range (0.249–0.500).
(TIF)
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